Cancer BiologyFrontiers in OncologyPeer-reviewed
Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: segue towards a precision medicine approach.
Y. K. Tai, K. K. W. Chan, C. H. H. Fong…·A. Franco-Obregon
This study shows TRPC1 expression predicts breast cancer sensitivity to doxorubicin and PEMF therapy, suggesting TRPC1 as a biomarker for precision medicine approaches.